Hyperthermic fibrinolysis with rt-PA: in vitro results

Cardiovasc Intervent Radiol. 1998 Mar-Apr;21(2):142-5. doi: 10.1007/s002709900231.

Abstract

Purpose: To investigate the influence of hyperthermia up to 45 degrees C on fibrinolysis with recombinant tissue-type plasminogen activator (rt-PA).

Methods: Standardized fibrin clots were incubated in a water bath for 5 hr with either rt-PA (test group) or 0.9% sodium chloride (control group) and blood plasma at temperatures of 30-45 degrees C. Concentrations of D-dimer and time to complete clot lysis were measured.

Results: The activity of fibrinolysis with rt-PA rose with increasing temperature: time to lysis approximately halved from 30 degrees C to 40 degrees C and the concentration of D-dimer tripled. In the control group clot size did not change.

Conclusions: Activity of rt-PA-induced fibrinolysis rises distinctly with higher temperatures. Since even healthy subjects show a physiologic decline in body temperature in the extremities, in patients with occlusive arterial disease decreased activity of fibrinolysis with rt-PA can be expected. Controlled hyperthermia may improve fibrinolysis with rt-PA and should be investigated in vivo.

MeSH terms

  • Fibrinolysis / drug effects*
  • Hot Temperature*
  • Humans
  • Hyperthermia, Induced
  • In Vitro Techniques
  • Recombinant Proteins / therapeutic use
  • Thrombolytic Therapy / methods
  • Tissue Plasminogen Activator / pharmacology*
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Recombinant Proteins
  • Tissue Plasminogen Activator